3 Patents
- US122470782025ERBB-2 and ERBB-3 Binding Bispecific Antibodies for Use in the Treatment of Cells That Have an NRG1 Fusion Gene
Merus N.V.
0 cites - US121955512025Combination of an Erbb-2/erbb-3 Bispecific Antibody with Endocrine Therapy for Breast Cancer
Merus N.V.
0 cites